Like a candy bar, a ride into town or even a welcome to dinner from someone who lived along the trail. A simple way to describe it is an unexpected kindness from a stranger along the way - something given that wasn’t asked for. In her updates as she hiked, she wrote of something called “trail magic” that I had never heard of. Assignors: TALLIKUT PHARMACEUTICALS, INC.There is a young woman, Emma, who is very special to me (kind of like a godchild) who took a semester off of college to thru-hike the Appalachian Trail - all 2,180+ miles of it from Georgia to Maine - by herself. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PONIARD (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC Assigned to ACCELERATED PHARMA, INC. Assigned to PONIARD (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC reassignment PONIARD (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). reassignment TALLIKUT PHARMACEUTICALS, INC. Assigned to TALLIKUT PHARMACEUTICALS, INC. RELEASE OF SECURITY INTEREST Assignors: SCHWEGMAN, LUNDBERG& WOESSNER, P.A. reassignment POINARD PHARMACEUTICALS, INC. Application granted granted Critical Publication of US8168662B1 publication Critical patent/US8168662B1/en Assigned to POINARD PHARMACEUTICALS, INC. reassignment SCHWEGMAN, LUNDBERG& WOESSNER, P.A. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to US85706606P priority Critical Priority to US85772506P priority Priority to US87749506P priority Priority to US88919107P priority Priority to US93158907P priority Priority to US98385207P priority Priority to US98284107A priority Priority to US12/508,372 priority patent/US8168662B1/en Application filed by Poniard Pharmaceuticals Inc filed Critical Poniard Pharmaceuticals Inc Assigned to SCHWEGMAN, LUNDBERG& WOESSNER, P.A. Original Assignee Poniard Pharmaceuticals Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Weiden Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Expired - Fee Related, expires Application number US12/508,372 Inventor David A. Google Patents Use of picoplatin to treat colorectal cancerĭownload PDF Info Publication number US8168662B1 US8168662B1 US12/508,372 US50837209A US8168662B1 US 8168662 B1 US8168662 B1 US 8168662B1 US 50837209 A US50837209 A US 50837209A US 8168662 B1 US8168662 B1 US 8168662B1 Authority US United States Prior art keywords picoplatin administered leucovorin dose weeks Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US8168662B1 - Use of picoplatin to treat colorectal cancer US8168662B1 - Use of picoplatin to treat colorectal cancer
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |